Likewise, in acute viral hepatitis, an elevated urinary iron elimination following DF administration has been reported for more than 2 years (Schnack & Wewalka, 1964; Dobrilla et al., 1966) . In thirty-eight hepatitis patients Scuro et al. (1966) found post-DF sideruria values significantly increased in respect to the controls (Table 1) . Quite (6, 8 and, exceptionally, even 10 mg/24 hr) such as those usually found only in overt hypersiderotic situations. This elevated iron excretion can be erroneously evaluated if the factors which determine it are not considered. Indeed, in spite of frequently positive desferrioxamine tests, there is reason to believe that in the specific case of viral hepatitis such results do not express the existence of an actual hypersiderosis. In addition to the disputable hepatosiderosis two further explanations are feasible regarding the high post-DF sideruria in viral hepatitis: (1) that it is due to a concomitant haemolytic condition, and (2) that it is attributable to a release of iron (free or ferritin-Fe) in the blood by necrotic hepatocytes.
We would like to briefly discuss the abovementioned possibilities.
Post-DF sideruria and hepatic siderosis Hult (1952) (Pitcher & Williams, 1963) . It is thus quite reasonable to ask oneself whether the high post-DF excretion in this disease does not depend upon the lowered erythrocyte survival rate; Smith, Studley & Williams (1967) are oriented in this direction. Indeed, it has been shown that under various anaemic conditions of an overtly haemolytic nature, the post-DF sideruria values may be very high, quite similar to those observed in hypersiderotic sub-jects (Fielding, 1965) . Fielding explains this phenomenon by suggesting that DF is able to chelate the iron which originates from haemoglobin catabolism.
In confirmation of this, O'Shaughnessy, Brunstrom & Fielding (1966) report that in traumatized subjects having haematomas DF provokes a marked urinary iron elimination, so precocious that it cannot be explained by an increase in the storage iron proteins, but only by a DF chelation of intermediates derived from haemoglobin degradation. More recently, Fielding (1967) cites, in support of his opinion, the results of Cumming et al. (1967) who were able to increase the post-DF sideruria by inducing haemolysis with phenylhydrazine in both man and animal.
Fielding's interpretation appears interesting: desferrioxamine B, capable of removing iron from complex molecules such as ferritin and haemosiderin, should be able to chelate the iron resulting from haemoglobin catabolism to a greater extent, since in this dynamic metabolic phase iron has yet to acquire stable and complex bonds. Nevertheless, in agreement with Ventura (1967) , other considerations and other data must be taken into account before accepting this hypothesis without reserve.
First of all, during protracted DF administration, whatever the iron deposition, and, consequently, the iron elimination may be, one observes an always variable and progressively de- (Ventura, 1967) .
Fourthly, in the case of thalassaemia major where the haemolysis is of indisputable gravity, one observes abnormal post-DF sideruria only if numerous transfusions have been given (some 15-16 g of Fe), while one notes a urinary iron excretion significantly lower, if the transfused iron is less (approximately 8 g) (McDonald, 1966 Scuro and G. Dobrilla (1956) are conclusive in that they have directly shown the existence of ferritin in the blood of hepatitis patients by an immunological procedure. Can this peculiar increase in serum Fe explain the high post-DF sideruria? Several considerations and various experimental data seem to confirm this. It is in fact known that ferritin is the iron-protein which is most readily chelated by desferrioxamine. The removal of the metal from haemosiderin is indeed slower, while the DFchelation from transferrin is with certainty demonstrated only in vitro. In acute viral hepatitis in which circulating ferritin is present, conditions are most favourable for desferrioxamine to exert its chelating action in the blood itself. If this assumption is true, in this disease the elevated post-DF sideruria should be associated with a decrease in the serum iron levels.
Our studies (Scuro et al., , 1967 fully confirm this hypothesis (Fig. 1) . In the first 6 hr Also haemolysis, present to a more or less marked extent, can to a certain degree influence the DF test. This influence seems to manifest itself in an indirect manner since it has been seen that it is insufficient per se to always provoke an elevated urinary iron excretion. Nevertheless, it remains, in our opinion, a less important factor in respect to that represented by hepatonecrosis.
Finally, we hold that the elevated post-DF sideruria in acute viral hepatitis does not depend upon liver siderosis, a picture excluded by morphological studies. The results of the DF test in the hepatitis subject, which would suggest an iron overload condition, must then be considered 'false positive'.
